MODTX — Modus Therapeutics Holding AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK65.77m
- SEK50.37m
Annual balance sheet for Modus Therapeutics Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.38 | 7.34 | 20.6 | 10.4 | 19.1 |
| Net Total Receivables | 0.634 | 0.138 | 0.249 | 0.23 | 0.671 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.05 | 7.49 | 21.1 | 11.2 | 20 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.05 | 7.49 | 21.2 | 11.3 | 20 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.74 | 0.496 | 5.46 | 13.9 | 2.36 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.74 | 0.496 | 5.46 | 13.9 | 2.36 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.69 | 7 | 15.7 | -2.58 | 17.7 |
| Total Liabilities & Shareholders' Equity | 2.05 | 7.49 | 21.2 | 11.3 | 20 |
| Total Common Shares Outstanding |